He had stopped Coumadin in [**2130**] and otherwise had not noticed any sudden sharp pain, had not had any episodes of syncope and had not noticed any shortness of breath.
The patient had been on Coumadin since [**2128-2-5**] and had stopped this medication in [**2130**].
He has a history of coronary artery disease, status post myocardial infarction in [**2121**] and coronary artery bypass grafting.
The patient has a history of abdominal aortic aneurysm, status post repair in [**2121**].
He has a history of hypercholesterolemia, idiopathic thrombocytopenic purpura, status post splenectomy, and hairy cell leukemia.
The patient is status post hernia repair and has a history of hypothyroidism and depression.
MEDICATIONS ON ADMISSION:  Aspirin 81 mg p.o.
q day, Flomax 0.4 mg p.o.
q day, Plavix 75 mg p.o.
q day, Restoril 15 mg p.o.
p.r.n., Synthroid 50 mcg p.o.
q day, Effexor 37.5 mg p.o.
b.i.d., Celexa 20 mg p.o.
q day, Vioxx 25 mg p.o.
q day, Trazodone 25 mg p.o.
q h.s., Heparin 5000 units subcutaneously b.i.d., Macrobid 100 mg p.o.
for a recent urinary tract infection, standing Tylenol and Morphine p.r.n.
Soft, non-tender and obese.
Status post splenectomy and hernia repair.
We were concerned at that time about increased bleeding risk with a fall given that the patient was no a Heparin drip and supratherapeutic at that time.
LABORATORIES ON ADMISSION:  The patient's white count was 7.4, hemoglobin 17.0 and hematocrit 48.9 with platelets of 212.
HOSPITAL COURSE:  Given the above, the patient was admitted to the Medicine Service and was treated for his pulmonary embolus with a Heparin drip and Coumadin.
The patient was therapeutic on the Heparin drip and subsequently on the Coumadin throughout his hospital stay.
The patient was continued on Midodrine and titrated up to a dose of 7.5 mg t.i.d.
Given the above, the Vascular Surgery Service was consulted and recommended non-invasive arterial studies of the lower extremities and who continued to follow and suggested outpatient follow up for these findings.
The Medicine Service was reluctant, at first, to begin any beta blockers or calcium channel blockers given the patient's history of AV conduction block and given his fluctuating neurologic symptoms with decreased blood pressure.
However, once the patient's blood pressure stabilized, the patient was begun on a low dose of Lopressor (12.5 mg p.o.
Otherwise, for his history of coronary artery disease, the patient was continued on aspirin and Plavix.
However, he was ruled out for myocardial infarction each time and otherwise was continued on telemetry generally throughout his hospital stay.
They felt that phlebotomy was not necessary at this time and that the erythrocytosis may be secondary to dehydration and chronic hypoxemia secondary to pulmonary emboli and chronic obstructive pulmonary disease.
They recommended Erythromycin eyedrops for presumed conjunctivitis and more frequent lubricants and hot compresses.
For the above, the patient was switched from Macrobid to Levaquin for a total fourteen day course.
Finally, the patient was seen by Physical Therapy and Occupational Therapy once his blood pressure became more stable with good effect.
Digoxin 0.125 mg p.o.
Midodrine 5 mg p.o.
Metoprolol 12.5 mg p.o.
Warfarin 0.5 mg p.o.
Lipitor 10 mg p.o.
Erythromycin 0.5% ophthalmic solution 1 drop in both eyes t.i.d.
Ambien 5 mg p.o.
Tylenol p.r.n.
Colace 100 mg p.o.
Dulcolax 10 mg p.o.
Lactulose 30 ml p.o.
Senna 2 tablets p.o.
Oxycodone sustained release 10 mg p.o.
Protonix 40 mg p.o.
Levaquin 250 mg p.o.
Levoxyl 50 mcg p.o.
Plavix 75 p.o.
Aspirin 81 mg p.o.
